Kevin J. Knopp, who serves as President and Chief Executive Officer of 908 Devices Inc (NASDAQ:MASS), completed a sale of company stock on February 2, 2026. The transaction involved 34,764 shares of common stock and produced proceeds of approximately $214,841. The shares were disposed of at a weighted average price per share ranging from $6.105 to $6.32.
One day earlier, on February 1, 2026, Knopp exercised Restricted Stock Units and received 108,999 shares of Common Stock as a result of that exercise.
Financial updates reported by the company
Separately from the insider transactions, 908 Devices disclosed preliminary unaudited revenue figures for the full year 2025 of approximately $56 million, representing a 17% increase over the prior year. The company said fourth-quarter revenue rose 20% to about $17.2 million, compared with $14.3 million in the fourth quarter of 2024.
In the company’s third quarter of 2025, reported results showed that revenue exceeded consensus expectations, with $14 million in sales versus an anticipated $13.52 million. However, the period revealed a larger-than-expected loss on a per-share basis, with an EPS loss of $0.41 compared with a forecasted loss of $0.14. The company also noted it has met a positive EBITDA target.
What is known and what remains limited
The record shows a sequence of corporate equity actions by the CEO: the exercise of restricted stock units on February 1, 2026, followed by the sale of a portion of shares received on February 2, 2026. The firm’s preliminary full-year and quarterly revenue figures reflect year-over-year growth as reported by the company. The Q3 2025 results combined a revenue beat with a wider-than-expected EPS loss.
No additional context, commentary from company officials, or further details about future plans were provided in the disclosures referenced here.